4 unchanged sentences
We are vigorously defending against this claim.
−Removed: On September 23, 2019, in a complaint filed in the Düsseldorf, Germany, District Court, Micromass UK Limited (Micromass), a subsidiary of Waters Corporation, sued Bruker Corporation, as well as its affiliate, Bruker Daltonik GmbH, for infringement of a European patent pertaining to our timsTOF product line.
−Removed: Bruker was later notified that Micromass had expanded its complaint in Düsseldorf to assert another recently granted European patent in Germany.
−Removed: On March 5, 2021, the parties entered into a Patent License Agreement pursuant to which Bruker licensed certain patents from Micromass and agreed to pay a one-time, upfront $4.0 million payment in the second quarter of 2021 and agreed to pay royalties, subject to a quarterly minimum, on certain TimsTOF systems commencing March 1, 2022.
−Removed: In addition, pursuant to the Patent License Agreement, all claims between the parties in connection with this and other pending infringement matters were settled and dismissed with prejudice.
−Removed: The settlement of this matter did not and is not expected to materially impact the Company’s results of operations.
In addition, we are subject to regulation by national, state and local government agencies in the United States and other countries in which we operate.
13 unchanged sentences
In an effort to halt the outbreak of COVID-19,
−Removed: a number of countries, including the United States, have implemented and continue to implement significant restrictions on travel, shelter in place or stay at home orders, and business closures.
+Added: a number of countries, including the United States, have implemented and some continue to implement significant restrictions on travel, shelter in place or stay at home orders, and business closures.
While some of these restrictions are loosening in certain jurisdictions, some markets have returned to restrictions in the face of increases in new COVID-19
cases or new strains of the virus.
−Removed: A number of states, including California, Massachusetts and New Jersey where we have significant operations, have implemented phased re-opening
+Added: A number of states, including California, Massachusetts and New Jersey where we have significant operations, have implemented re-opening
policies as vaccines to protect against the virus continue to be administered.
1 unchanged sentence
may be delayed or pulled back if the virus continues to spread or as new strains of the virus emerge, in particular if existing vaccines are determined to be less effective against these new strains than against earlier strains.
−Removed: In addition, a number of our production facilities had to either temporarily close or operate on a reduced capacity in 2020.
+Added: In addition, while some parts of the world are beginning to resume pre-pandemic
+Added: business operations, certain Asia Pacific geographies where we operate are continuing to experience significant disruptions relating to COVID-19.
Much of the commercial activity in sales and marketing, and customer demonstrations and applications training, is still either being conducted remotely or postponed.
−Removed: Many customer purchasing departments are still operating at reduced capacity, and many customers could delay or cut capital expenditures and operating budgets due to ongoing pandemic-related concerns.
+Added: Customer purchasing departments could operate at reduced capacity and customers could delay or cut capital expenditures and operating budgets due to ongoing pandemic-related concerns.
Even where customers have re-opened
−Removed: their sites, many still operate at productivity levels that are below pre-pandemic
−Removed: levels in an effort to accommodate safety
+Added: their sites, some still operate at productivity levels
+Added: that are below pre-pandemic
+Added: levels in an effort to accommodate safety protocols and as a result of pandemic-related supply chain disruptions.
Any resurgence of the virus or the emergence of new strains of the virus, particularly any new strains which are resistant to existing vaccines, may require us or our customers to close or partially close operations once again.
−Removed: These travel restrictions, business closures and operating reductions at Bruker, our customers, our distributors, and/or our suppliers have and may continue to adversely impact our operations worldwide, including our ability to manufacture, sell or distribute our products, as well as cause temporary closures of our foreign distributors, or the facilities of suppliers or customers.
−Removed: Global supply chains, including for semiconductor chips and other component products, have been disrupted causing shortages, which could impact our ability to manufacture or supply our products.
−Removed: This disruption of our employees, distributors, suppliers or customers has and may continue to impact our global sales and future operating results.
−Removed: We anticipate that the COVID-19
−Removed: pandemic and challenges to our customers’ and our own operations may continue to have a negative impact on our second quarter 2021 financial results.
+Added: These travel restrictions, business closures and operating reductions at Bruker, our customers, our distributors, and/or our suppliers have in the past adversely impacted and may continue to adversely impact our operations worldwide, including our ability to manufacture, sell or distribute our products, as well as cause temporary closures of our foreign distributors, or the facilities of suppliers or customers.
+Added: Global supply chains, including for semiconductor chips, components and raw materials such as copper, have been disrupted, causing shortages, which could impact our ability to manufacture or supply our products.
+Added: We could also experience increased compensation expenses associated with employee recruiting and employee retention to the extent employment opportunities start multiplying post-pandemic, causing the search for and retention of talent to become more competitive.
+Added: This disruption of our employees, distributors, suppliers and customers has historically impacted and may continue to impact our global sales and future operating results.
We are continuing to monitor and assess the effects of the COVID-19
−Removed: pandemic on our commercial operations, including its continued impact on our revenue in 2021.
−Removed: However, we cannot at this time accurately predict what effects these conditions will ultimately have on our operations due to uncertainties relating to the severity of the disease, including the impact of any resurgence of the virus, the continued emergence of new strains of the virus, the effectiveness and availability of vaccines, the willingness of individuals to receive vaccines, (including to protect against any new strains of the virus), and the length or severity of the travel restrictions, business closures, and other safety and precautionary measures imposed by the governments of impacted countries.
+Added: pandemic on our commercial operations in 2021.
+Added: However, we cannot at this time accurately predict what effects these conditions will ultimately have on our operations due to uncertainties relating to the severity of the disease, including the impact of any resurgence of the virus, the continued emergence of new strains of the virus, the effectiveness and availability of vaccines, the willingness of individuals to receive vaccines, (including to protect against any new strains of the virus), and the length or severity of travel restrictions, business closures, and other safety and precautionary measures imposed by the governments of impacted countries.
The pandemic has also adversely affected the economies and financial markets of many countries, which has affected and likely may continue to affect demand for the Company’s products and its operating results.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.